Sequenta

Immune medicine company decoding the adaptive immune system for disease treatment

placeSan Francisco, California, United States calendar_todayFounded 2008 groups58 employees language sequenta.com

Registered entities

Investor mix

6 investors on record; lead investors include Index Ventures.

Investor typeCountShare
Venture capital467%
Accelerator & incubator117%
Other / undisclosed117%
Coming soon